Radiopharm Theranostics Limited Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets
Radiopharm Theranostics Limited (RADX) reported Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets of $2.16 million for the 12-month period ending 2025-06-30, per its 20-F filed 2025-09-18.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets · last filed 2025-09-18
| Period end | Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets 12 month |
|---|---|
| 2025-06-30 | $2.16M 20-F · filed 2025-09-18 |
| 2024-06-30 | $3.03M 20-F · filed 2025-09-18 |
| 2023-06-30 | $4.22M 20-F · filed 2025-09-18 |